TWO ยท Financial Statements

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Financial Statements

$8.85 TWO: 4157.TWO Market Cap $6.36B

Full income statement, balance sheet, and cash flow statement for TaiGen Biopharmaceuticals Holdings Limited (4157.TWO), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
4157.TWO Overview 4157.TWO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.